The global hematopoietic stem cells transplantation (HSCT) market is expected to grow at an impressive CAGR of close to 6% during the forecast period, according to Technavio's latest market research.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171016005794/en/
Technavio has published a new report on the global HSCT market from 2017-2021. (Graphic: Business Wire)
In this market research report, Technaviocovers the market outlook and growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. The market is further categorized into therapeutic applications (AML, ALL, HL and NHL, CML, MM, and others) and by transplant (autologous transplant and allogenic transport).
Technavio's research analysts segment the global HSCT market into the following regions:
- Americas
- APAC
- EMEA
Looking for more information on this market? Request a free sample report
Technavio's sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
EMEA: largest HSCT market
The rising awareness and developed healthcare infrastructure in Europe are propelling the demand for HSCT in this region. The growth in effective treatment facilities in countries such as the UK, Spain, Italy, France, and Germany will help boost the growth of the HSCT market in the EMEA region. The prevalence of blood-cancer and other related disorders is creating different product opportunities for vendors in this market. The HSCT market in EMEA occupied around 50% of the total market share in 2016.
"The presence of a varied patient pool with different types of tobacco and alcohol-related cancers and growing number of bone marrow registry and cord blood banks will propel the growth of the HSCT market in EMEA. These banks are the primary source for a genetic match and HSC. The application of HSCT in other diseases such as autoimmune disease, cardiovascular disease, neurological disease, and other blood-related disorders is expected to fuel the demand for HSCT in EMEA," says Sapna Jha, a lead research expert at Technavio for infectious and rare diseases.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free
HSCT market in the Americas
In 2016, the HSCT market in the Americas accounted for more than 32% of the total market share. The increasing investments to offer superior and better healthcare services will create new opportunities for vendors in the market. The rising number of new registries will propel the demand for HSCT related products in the market. The increasing usage of HSCT as an indispensable part of the treatment regimen for various types of autoimmune diseases, blood cancers, and neurologic disorders will have a positive impact on the overall growth of the market.
HSCT market in APAC
The rapid growth in countries like India and China will boost the supply of HSCT related products in the APAC market. Japan dominated the HSCT market in APAC. The rising prevalence of blood cancer and other related disorders will aid in the growth of the market in this region. The growing awareness about HSCT among physicians for treating autoimmune diseases, neurological diseases, and other malignancies that require high doses of chemotherapy will create growth opportunities for vendors in APAC. The HSCT market in APAC occupied close to 18% of the total market share in 2016. The increase in disposable income of people in this region, large population base, and increase in medical tourism will fuel the development of the HSCT market in APAC.
"The growth of the HCST market in APAC is attributed to the improvements in healthcare infrastructure, rising healthcare expenditure, technological advancement, and growing demand for better healthcare services. The rise in the number of bone marrow registries and stem cell preservation centers is expected to have a positive impact on the region's market growth," says Sapna
The top vendors in the global HSCT market as highlighted in this market research analysis are:
- AllCells
- Lonza
- Merck
- Sanofi
Browse Related Reports:
- Global Bacterial Vaginosis Drugs Market 2017-2021
- Global Antibiotics Market 2017-2021
- Global Animal Growth Enhancers Market 2017-2021
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171016005794/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com